Skip to content

Ifosfamide

Published: July 26, 2026Updated: July 26, 2026

Ifosfamide is an antineoplastic alkylating agent used in the treatment of various cancers, including testicular cancer, soft tissue sarcomas, and certain lymphomas. It is a prodrug that requires metabolic activation by hepatic cytochrome P450 enzymes to produce its cytotoxic metabolites, which work by cross-linking DNA and interfering with DNA replication in rapidly dividing cells.

Quick summary

Ifosfamide is a chemotherapy drug that treats certain cancers by damaging cancer cell DNA after being activated by liver enzymes.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
L01AA06
RxNorm
5657
Generic
Ifosfamide
Class
atc-l01
Brands
Ifex
Availability
rx
Lactation
unknown
Routes
—
Forms
injection
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose above 10 g may cause serious or fatal toxicity including severe myelosuppression, neurotoxicity, and hemorrhagic cystitis
Chronic overdose: Cumulative doses exceeding 60-80 g/m² associated with increased risk of hemorrhagic cystitis, neurotoxicity, and renal dysfunction
Immediate actions
Gastric lavage within 1-2 hours of ingestion if large dose, activated charcoal, vigorous IV hydration, administer mesna to prevent hemorrhagic cystitis, monitor urine output
Antidote
No specific antidote exists(Treatment is supportive; early intervention with hydration and mesna reduces complications)
Poison Control: 1-800-222-1222

Special Populations

10 groups
✗

pregnancy

first trimester
unsafe
FDA Category
D
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks; discuss potential fetal harm with patient

Monitor

regular fetal monitoring, ultrasound assessments

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pregnancy

second trimester
caution
FDA Category
D
Dose Adjustment

use only if clearly needed

Key Recommendations

use only when benefits outweigh risks; consider alternative therapies when possible

Monitor

fetal growth monitoring, regular ultrasounds

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
D
Dose Adjustment

use only if clearly needed

Key Recommendations

consider delaying treatment until after delivery if clinically appropriate

Monitor

fetal monitoring, assessment of fetal well-being

Use with caution and monitor for adverse effects.

✗

lactation

breastfeeding
contraindicated
FDA Category
N
Dose Adjustment

discontinue breastfeeding

Key Recommendations

do not breastfeed during ifosfamide treatment and for at least 24 hours after last dose

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly over 65
caution
FDA Category
N
Dose Adjustment

consider dose reduction

Key Recommendations

use with caution; start at lower end of dosing range; monitor renal and hepatic function

Monitor

monitor renal function, hepatic function, complete blood counts

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children under 18
caution
FDA Category
N
Dose Adjustment

weight-based dosing required

Key Recommendations

used in pediatric cancers; doses calculated by body surface area; monitor for hemorrhagic cystitis

Monitor

monitor CBC, renal function, urinalysis for hematuria

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe renal impairment
caution
FDA Category
N
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

reduce dose in patients with creatinine clearance <30 mL/min; monitor renal function closely

Monitor

frequent monitoring of renal function, serum electrolytes

Use with caution and monitor for adverse effects.

⚠

renal_impairment

moderate renal impairment
caution
FDA Category
N
Dose Adjustment

reduce dose by 15-25%

Key Recommendations

adjust dose based on creatinine clearance; consider hydration protocol

Monitor

monitor renal function before each cycle

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

severe hepatic impairment
caution
FDA Category
N
Dose Adjustment

use with extreme caution

Key Recommendations

use only if benefits outweigh risks; ifosfamide is metabolized in liver

Monitor

monitor hepatic function tests, bilirubin

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate hepatic impairment
caution
FDA Category
N
Dose Adjustment

no major adjustment needed

Key Recommendations

use with caution; monitor liver function tests

Monitor

regular hepatic function monitoring

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1988

General prescribing information

drug_classWHO
2023

Drug class

Value:Alkylating agent (oxazaphosphorine)

Drug class information

usageMedical guidelines
2023

Common uses

Value:Testicular cancer, bladder cancer, ovarian cancer, sarcomas, lymphomas

Common therapeutic uses

pharmacologyFDA
2023

Mechanism of action

Value:DNA cross-linking agent

Pharmacological mechanism

Ifosfamide is primarily used to treat testicular cancer, soft tissue and bone sarcomas (including osteosarcoma and Ewing's sarcoma), Hodgkin's and non-Hodgkin's lymphomas, and is sometimes used for other solid tumors such as cervical cancer and lung cancer. It is often used in combination regimens when other treatments have been insufficient.

Ifosfamide is a prodrug that requires activation by hepatic cytochrome P450 isoenzymes, particularly CYP3A4. This metabolic activation produces 4-hydroxyifosfamide and related cytotoxic metabolites that function as alkylating agents, causing cross-linking of DNA strands and preventing DNA replication and cell division in rapidly proliferating cancer cells.

Ifosfamide carries a significant risk of hemorrhagic cystitis (bladder bleeding), which is typically prevented with mesna (a uroprotective agent) and aggressive hydration. Other important side effects include myelosuppression, nephrotoxicity, neurotoxicity, and alopecia. Due to its teratogenic potential, it should not be used during pregnancy. Close monitoring of blood counts, kidney function, and neurologic status is required during treatment.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy